|
Name |
Trichomide B
|
Molecular Formula | C31H53N5O7 | |
IUPAC Name* |
(3R,10S,13S,16S,19S,20S)-13,16-bis[(2S)-butan-2-yl]-10,11,20-trimethyl-3-(2-methylpropyl)-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
|
|
SMILES |
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N([C@H](C(=O)NCCC(=O)O[C@@H](C(=O)N2CC[C@@H]([C@H]2C(=O)N1)C)CC(C)C)C)C)[C@@H](C)CC
|
|
InChI |
InChI=1S/C31H53N5O7/c1-10-18(5)24-28(39)34-25(19(6)11-2)31(42)35(9)21(8)27(38)32-14-12-23(37)43-22(16-17(3)4)30(41)36-15-13-20(7)26(36)29(40)33-24/h17-22,24-26H,10-16H2,1-9H3,(H,32,38)(H,33,40)(H,34,39)/t18-,19-,20-,21-,22+,24-,25-,26-/m0/s1
|
|
InChIKey |
YQOPTYPRANXBLW-YVJFYBQISA-N
|
|
Synonyms |
Trichomide B
|
|
CAS | NA | |
PubChem CID | 102435899 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 607.8 | ALogp: | 3.4 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 154.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 43 | QED Weighted: | 0.391 |
Caco-2 Permeability: | -5.294 | MDCK Permeability: | 0.00000935 |
Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.96 |
Human Intestinal Absorption (HIA): | 0.095 | 20% Bioavailability (F20%): | 0.556 |
30% Bioavailability (F30%): | 0.865 |
Blood-Brain-Barrier Penetration (BBB): | 0.13 | Plasma Protein Binding (PPB): | 82.78% |
Volume Distribution (VD): | 0.587 | Fu: | 5.82% |
CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.039 |
CYP2C19-inhibitor: | 0.076 | CYP2C19-substrate: | 0.367 |
CYP2C9-inhibitor: | 0.099 | CYP2C9-substrate: | 0.039 |
CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.064 |
CYP3A4-inhibitor: | 0.854 | CYP3A4-substrate: | 0.234 |
Clearance (CL): | 6.142 | Half-life (T1/2): | 0.664 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.889 |
Drug-inuced Liver Injury (DILI): | 0.77 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.552 | Maximum Recommended Daily Dose: | 0.407 |
Skin Sensitization: | 0.05 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.021 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003706 | 0.855 | D0L7LC | 0.285 | ||||
ENC003645 | 0.614 | D02SBQ | 0.283 | ||||
ENC003175 | 0.396 | D08FJL | 0.281 | ||||
ENC005469 | 0.396 | D0D8XY | 0.266 | ||||
ENC002373 | 0.390 | D00ZCN | 0.261 | ||||
ENC005563 | 0.380 | D05AFC | 0.256 | ||||
ENC003254 | 0.369 | D0J7XL | 0.255 | ||||
ENC005449 | 0.365 | D0M3FJ | 0.254 | ||||
ENC002515 | 0.343 | D0O3YF | 0.252 | ||||
ENC005343 | 0.340 | D0L9HX | 0.249 |